ÖSTROGENREZEPTOR-ANTAGONISTEN

Patent europeic · EP4310079 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4310079
Numer da la dumonda
EP22770451
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
14-03-2022
Publitgà
24-01-2024
Concedì
17-06-2026
La protecziun finescha il pli tard
13-03-2042
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
C07D 498/04 (2006.01)
C07D 519/00 (2006.01)
A61P 35/00 (2006.01)
A61K 31/4738 (2006.01)
Prioritad
CN 202110277849 15.03.2021
Dumonda PCT
PCT/CN2022/080680 14.03.2022
Publicaziun PCT
WO2022/194096 22.09.2022
Lingua da l’annunzia
chinais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 09-07-2026

    Represchentant inscrit

    Representative
    Synergy IP Group AG, Unterer Rheinweg 50, 4057 Basel

    Published in Swissreg on 09.07.2026

  2. 17-06-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 17.06.2026

Partidas

Possessur

Shenzhen Forward Pharmaceuticals Co., Limited

B302, 19 Gaoxin S. 7th Ave. Nanshan District, Shenzhen, Guangdong 518067, CN

Represchentant

Synergy IP Group AG

Unterer Rheinweg 50, 4057 Basel

Inventur

YANG, Xuan

Shenzhen, Guangdong 518067, CN

ZHU, Chenggang

Shenzhen, Guangdong 518067, CN

ZHANG, Chaochun

Shenzhen, Guangdong 518067, CN

TALLEY, John Jeffery

Shenzhen, Guangdong 518067, CN

CHEN, Chaole

Shenzhen, Guangdong 518067, CN

BAO, Liming

Shenzhen, Guangdong 518067, CN

MIN, Xiangyan

Shenzhen, Guangdong 518067, CN

XU, Liangliang

Shenzhen, Guangdong 518067, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.